Amgen Acquires BioVex for $1,000,000,000

  • Feed Type
  • Date
    1/25/2011
  • Company Name
    BioVex
  • Mailing Address
    34 Commerce Way Woburn, MA 01801
  • Company Description
    The Company is developing a new class of potent biologics for the treatment
    of cancer and prevention of infectious disease.
  • Website
    http://www.biovex.com
  • Transaction Type
    M&A
  • Transaction Amount
    $1,000,000,000
  • Transaction Round
  • Proceeds Purposes
  • M&A Terms
    Under terms of the agreement, Amgen will pay up to $1 billion: $425 million in cash at closing and up to $575 million in additional payments upon the achievement of certain regulatory and sales milestones.